{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:41:21Z","timestamp":1770291681819,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Liga Portuguesa Contra o Cancro (PT), N\u00facleo Regional do Centro","award":["Research grant Dr. Rocha Alves"],"award-info":[{"award-number":["Research grant Dr. Rocha Alves"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13187-019-01562-x","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T20:04:22Z","timestamp":1561147462000},"page":"1026-1033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-3650","authenticated-orcid":false,"given":"Raquel Gomes","family":"Martins","sequence":"first","affiliation":[]},{"given":"Irene Palmares","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"issue":"2","key":"1562_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PL Dahia","year":"2014","unstructured":"Dahia PL (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14(2):108\u2013119. \nhttps:\/\/doi.org\/10.1038\/nrc3648","journal-title":"Nat Rev Cancer"},{"key":"1562_CR2","doi-asserted-by":"publisher","unstructured":"Lenders, J. W., Duh, Q. Y., Eisenhofer, G., Gimenez-Roqueplo, A. P., Grebe, S. K., Murad, M. H., Naruse M., Pacak K., Young WF Jr, Endocrine Society. (2014). Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 99(6), 1915\u20131942, doi:\nhttps:\/\/doi.org\/10.1210\/jc.2014-1498","DOI":"10.1210\/jc.2014-1498"},{"issue":"8","key":"1562_CR3","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1210\/jc.2005-2178","volume":"91","author":"C Jimenez","year":"2006","unstructured":"Jimenez C, Cote G, Arnold A, Gagel RF (2006) Review: should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab 91(8):2851\u20132858. \nhttps:\/\/doi.org\/10.1210\/jc.2005-2178","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1562_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/cen.12530","volume":"82","author":"JP Brito","year":"2015","unstructured":"Brito JP, Asi N, Bancos I, Gionfriddo MR, Zeballos-Palacios CL, Leppin AL, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH (2015) Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review. Clin Endocrinol 82(3):338\u2013345. \nhttps:\/\/doi.org\/10.1111\/cen.12530","journal-title":"Clin Endocrinol"},{"issue":"6","key":"1562_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1037\/0278-6133.21.6.564","volume":"21","author":"D Cella","year":"2002","unstructured":"Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C (2002) A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 21(6):564\u2013572","journal-title":"Health Psychol"},{"issue":"4","key":"1562_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10689-015-9811-2","volume":"14","author":"M Bjornslett","year":"2015","unstructured":"Bjornslett M, Dahl AA, Sorebo O, Dorum A (2015) Psychological distress related to BRCA testing in ovarian cancer patients. Familial Cancer 14(4):495\u2013504. \nhttps:\/\/doi.org\/10.1007\/s10689-015-9811-2","journal-title":"Familial Cancer"},{"issue":"5","key":"1562_CR7","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s10897-017-0090-y","volume":"26","author":"HS Lumish","year":"2017","unstructured":"Lumish HS, Steinfeld H, Koval C, Russo D, Levinson E, Wynn J, Duong J, Chung WK (2017) Impact of panel gene testing for hereditary breast and ovarian cancer on patients. J Genet Couns 26(5):1116\u20131129. \nhttps:\/\/doi.org\/10.1007\/s10897-017-0090-y","journal-title":"J Genet Couns"},{"issue":"2","key":"1562_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergencyto.2005.07.011","volume":"165","author":"HT Lynch","year":"2006","unstructured":"Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G (2006) Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 165(2):91\u201397. \nhttps:\/\/doi.org\/10.1016\/j.cancergencyto.2005.07.011","journal-title":"Cancer Genet Cytogenet"},{"key":"1562_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41431-018-0145-z","volume":"26","author":"AK Smit","year":"2018","unstructured":"Smit AK, Newson AJ, Best M, Badcock CA, Butow PN, Kirk J, Dunlop K, Fenton G, Cust AE (2018) Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma. Eur J Hum Genet 26:1094\u20131100. \nhttps:\/\/doi.org\/10.1038\/s41431-018-0145-z","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"1562_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1200\/jco.2006.07.3890","volume":"25","author":"KP Tercyak","year":"2007","unstructured":"Tercyak KP, Peshkin BN, Brogan BM, DeMarco T, Pennanen MF, Willey SC, Magnant CM, Rogers S, Isaacs C, Schwartz MD (2007) Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1\/2 gene testing. J Clin Oncol 25(3):285\u2013291. \nhttps:\/\/doi.org\/10.1200\/jco.2006.07.3890","journal-title":"J Clin Oncol"},{"issue":"2","key":"1562_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/pon.2106","volume":"22","author":"S Shiloh","year":"2013","unstructured":"Shiloh S, Dagan E, Friedman I, Blank N, Friedman E (2013) A follow-up study on men tested for BRCA1\/BRCA2 mutations: impacts and coping processes. Psychooncology 22(2):417\u2013425. \nhttps:\/\/doi.org\/10.1002\/pon.2106","journal-title":"Psychooncology"},{"issue":"2","key":"1562_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/pon.2080","volume":"22","author":"LG Aspinwall","year":"2013","unstructured":"Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA (2013) Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome. Psychooncology 22(2):276\u2013289. \nhttps:\/\/doi.org\/10.1002\/pon.2080","journal-title":"Psychooncology"},{"issue":"3","key":"1562_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/1055-9965.epi-11-0991","volume":"21","author":"KD Graves","year":"2012","unstructured":"Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD (2012) Long-term psychosocial outcomes of BRCA1\/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomark Prev 21(3):445\u2013455. \nhttps:\/\/doi.org\/10.1158\/1055-9965.epi-11-0991","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"1562_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/1055-9965.epi-09-0548","volume":"19","author":"KD Graves","year":"2010","unstructured":"Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Halbert CH (2010) Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 19(3):648\u2013654. \nhttps:\/\/doi.org\/10.1158\/1055-9965.epi-09-0548","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"32","key":"1562_CR15","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1200\/jco.2010.33.1561","volume":"29","author":"CH Halbert","year":"2011","unstructured":"Halbert CH, Stopfer JE, McDonald J, Weathers B, Collier A, Troxel AB, Domchek S (2011) Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? J Clin Oncol 29(32):4302\u20134306. \nhttps:\/\/doi.org\/10.1200\/jco.2010.33.1561","journal-title":"J Clin Oncol"},{"issue":"3","key":"1562_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0272989x10381283","volume":"31","author":"GW Hooker","year":"2011","unstructured":"Hooker GW, Leventhal KG, DeMarco T, Peshkin BN, Finch C, Wahl E, Joines JR, Brown K, Valdimarsdottir H, Schwartz MD (2011) Longitudinal changes in patient distress following interactive decision aid use among BRCA1\/2 carriers: a randomized trial. Med Decis Mak 31(3):412\u2013421. \nhttps:\/\/doi.org\/10.1177\/0272989x10381283","journal-title":"Med Decis Mak"},{"issue":"4","key":"1562_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ajmg.c.30104","volume":"142c","author":"SC O'Neill","year":"2006","unstructured":"O'Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H, Schwartz MD (2006) Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1\/2 test results. Am J Med Genet C Semin Med Genet 142c(4):251\u2013259. \nhttps:\/\/doi.org\/10.1002\/ajmg.c.30104","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"10","key":"1562_CR18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/pon.1467","volume":"18","author":"SC O'Neill","year":"2009","unstructured":"O'Neill SC, Rini C, Goldsmith RE, Valdimarsdottir H, Cohen LH, Schwartz MD (2009) Distress among women receiving uninformative BRCA1\/2 results: 12-month outcomes. Psychooncology 18(10):1088\u20131096. \nhttps:\/\/doi.org\/10.1002\/pon.1467","journal-title":"Psychooncology"},{"issue":"5","key":"1562_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1037\/a0015205","volume":"28","author":"C Rini","year":"2009","unstructured":"Rini C, O'Neill SC, Valdimarsdottir H, Goldsmith RE, Jandorf L, Brown K, DeMarco TA, Peshkin BN, Schwartz MD (2009) Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1\/2 results. Health Psychol 28(5):569\u2013578. \nhttps:\/\/doi.org\/10.1037\/a0015205","journal-title":"Health Psychol"},{"key":"1562_CR20","first-page":"16","volume-title":"Process of translation and adaptation of instruments. Accessed","author":"World-Health-Organization","year":"2016","unstructured":"World-Health-Organization (2016) Process of translation and adaptation of instruments. Accessed, pp 16\u201309-2016"},{"issue":"6","key":"1562_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"1562_CR22","unstructured":"Snaith, R. P., & Zigmond, A. P. (1994). The Hospital Anxiety and Depression Scale Manual. Windsor: NFER-Nelson"},{"issue":"2","key":"1562_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/13548500500524088","volume":"12","author":"J Pais-Ribeiro","year":"2007","unstructured":"Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M (2007) Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychol Health Med 12(2):225\u2013235; quiz 235-227. \nhttps:\/\/doi.org\/10.1080\/13548500500524088","journal-title":"Psychol Health Med"},{"issue":"6","key":"1562_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"issue":"3","key":"1562_CR25","first-page":"119","volume":"13","author":"PL Ferreira","year":"2000","unstructured":"Ferreira PL (2000) Development of the Portuguese version of MOS SF-36. Part II --validation tests. Acta Medica Port 13(3):119\u2013127","journal-title":"Acta Medica Port"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-019-01562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13187-019-01562-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-019-01562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T07:09:49Z","timestamp":1601363389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13187-019-01562-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1562"],"URL":"https:\/\/doi.org\/10.1007\/s13187-019-01562-x","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"value":"0885-8195","type":"print"},{"value":"1543-0154","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"assertion":[{"value":"21 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}